Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ocudyne

2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$2.01M LATEST DEAL AMOUNT
Description

Developer of therapies designed for age related macular degeneration. The company's therapies are integrated with advanced technoilogies, enabling patients to recover diseases.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • 2599 Cleveland Avenue
  • Roseville, MN 55113
  • United States

+1 (443) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ocudyne’s full profile, request a free trial.

Ocudyne Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 05-Feb-2019 $2.01M 00.00 Completed Startup
2. Angel (individual) 22-Aug-2017 00000 00.000 Completed Startup
1. Angel (individual) 25-Oct-2013 $1000K $1000K 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ocudyne Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Ocudyne Executive Team (3)

Name Title Board
Seat
Contact
Info
Jeffrey Franco Chief Executive Officer, Co-Founder, President & Chairman
Robert Atkinson Executive Officer & Board Member
Michael Calhoun Co-Founder

Ocudyne Board Members (4)

Name Representing Role Since Contact
Info
Jeffrey Franco Ocudyne Chief Executive Officer, Co-Founder, President & Chairman 000 0000
Joseph Smith Ocudyne Board Member 000 0000
Robert Atkinson Ocudyne Executive Officer & Board Member 000 0000

1 Former Board Member

You’re viewing 3 of 4 board members. Get the full list »